The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients

dc.authoridGenctoy, Gultekin/0000-0002-5145-2280
dc.authoridKiykim, Ahmet/0000-0001-9922-9267
dc.contributor.authorKuvandik, Gueven
dc.contributor.authorCetin, Meryem
dc.contributor.authorGenctoy, Gultekin
dc.contributor.authorHoroz, Mehmet
dc.contributor.authorDuru, Mehmet
dc.contributor.authorAkcali, Cenk
dc.contributor.authorSatar, Salim
dc.date.accessioned2024-09-18T21:06:32Z
dc.date.available2024-09-18T21:06:32Z
dc.date.issued2007
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBackground: Onychomycosis has a high prevalance among immunocompromised patients such as diabetics and hemodialysis patients. In the present study, we aimed to investigate the prevalence of onychomycosis among hemodialysis patients with and without diabetes mellitus, and to find out the factors likely to be associated with the development of onychomycosis among hemodialysis patients. Methods: One hundred and nine hemodialysis patients were enrolled. Fifty-seven of hemodialysis patients had the diagnosis of diabetes mellitus. Nail scrapings were obtained from 76 patients who had dystrophic nail changes. Samples were examined with 20% potassium hydroxide solution and all of the samples were inoculated on Saboraud's dextrose agar, potateus dextrose agar and mycobiotic agar. Diagnosis of onychomycosis was based on the presence of both positive clinical signs and positive potassium hydroxide test. Results: Onychomycosis was diagnosed in 26.6% of hemodialysis patients. Diabetes mellitus was present in 68.9% of patients with onychomycosis. Toenail scraping cultures were reported to be positive in 19.7% of patients with dystrophic nail changes. Logistic regression analysis revealed that the presence of diabetes mellitus and the mean duration of hemodialysis were the significant predictors associated with the development of onychomycosis. Conclusion: The prevalence of dystrophic nail changes and onychomycosis is increased among hemodialysis patients. The dialysis duration and the presence of diabetes mellitus are the independent risk factors associated with the development of onychomycosis in uraemic patients.en_US
dc.identifier.doi10.1186/1471-2334-7-102
dc.identifier.issn1471-2334
dc.identifier.pmid17760994en_US
dc.identifier.scopus2-s2.0-38349166980en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1186/1471-2334-7-102
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13672
dc.identifier.volume7en_US
dc.identifier.wosWOS:000252420900001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBmcen_US
dc.relation.ispartofBmc Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic-Renal-Failureen_US
dc.subjectDiabetic-Patientsen_US
dc.subjectMicro-Angiopathyen_US
dc.subjectNail Disordersen_US
dc.subjectSkin Changesen_US
dc.subjectPrevalenceen_US
dc.subjectInfectionsen_US
dc.subjectPopulationen_US
dc.titleThe prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
524.78 KB
Biçim:
Adobe Portable Document Format